Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.

@article{Venkatesh2013PersistentGT,
  title={Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load.},
  author={Kartik K Venkatesh and Allison K Delong and R. Kantor and Stacey Chapman and Jessica M Ingersoll and Jaclynn R Kurpewski and Maria Pia De Pasquale and R. O. D'Aquila and Angela M. Caliendo and Susan Cu-Uvin},
  journal={Journal of women's health},
  year={2013},
  volume={22 4},
  pages={330-8}
}
OBJECTIVE To longitudinally assess the association between plasma viral load (PVL) and genital tract human immunodeficiency virus (GT HIV) RNA among HIV-1 infected women changing highly active antiretroviral therapy (HAART) because of detectable PVL on current treatment. METHODS Women were eligible for the study if they had detectable PVL (defined as two consecutive samples with PVL>1000 copies/mL) and intended to change their current HAART regimen at the time of enrollment. Paired plasma and… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 36 references

HIV transmission: time for translational studies to bridge the gap.

Science translational medicine • 2011
View 6 Excerpts
Highly Influenced

Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission.

Science translational medicine • 2011
View 4 Excerpts
Highly Influenced

Prevention of HIV-1 infection with early antiretroviral therapy.

The New England journal of medicine • 2011
View 1 Excerpt

Similar Papers

Loading similar papers…